![]() |
|
|
Forward to a colleague |
||
Access Full Stories The UK has become an unlikely hub for drug counterfeiters, with the UK Medicines and Healthcare products Regulatory Agency (MHRA) last week launching its new three-year action plan to tackle the recent surge in... Read Paediatric drugs and testing highlighted The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego... Read Sanofi expands flu vaccines in China Sanofi-Aventis is to build a new influenza vaccine manufacturing facility in China... Read Singapore's pharma output continues to slow Singapore's biomedical manufacturing output was down again over October, stunting growth for the region's entire manufacturing sector... Read Regulators slate Roche 'lack of knowledge and understanding' in Viracept contamination case The official report into good manufacturing practice (GMP) failures that caused dangerous contamination and a Europe-wide recall of Roche's HIV drug Viracept (nelfinavir) claims the firm simply did not understand... Read |
|||||||||||||||||||
All News Headlines for: November | October | September |
|||||||||||||||||||
![]() SOF'BAG: the airless package to dispense creams, lotions and gels Rexam Pharma presents a total packaging system for transdermal and topical application. The SOF'BAG is easy-to-use for patients while keeping filling simple and logistics easy for drug manufacturers... Click Here | |||||||||||||||||||
Preclinical services news in brief In this week's review of activity within the preclinical research services arena, news has emerged involving ChemDiv, SRI International, ShangPharma, Ranbaxy and Xceleron... Read Targeted Genetics restarts trial after death The US Food and Drug Administration has allowed Targeted Genetics to restart testing its arthritis gene therapy after deciding the drug wasn't at fault when one person died in the original clinical trial... Read Exploring protein interactions in 'technicolour' A triple-colour bioluminescent assay has been developed that promises to speed-up high content screening (HCS) analysis by enabling multiple-target monitoring... Read Merck, Vertex halt aurora kinase cancer trial Merck & Co. and its partner Vertex Pharmaceuticals have stopped enrolling cancer patients to the clinical trial of its aurora kinase trial after one patient suffered heart problems... Read
|
|||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||